8-K: NorthStar Healthcare Income Announces Estimated Share Value Increase to $2.96

NorthStar Healthcare Income has set its estimated share value at $2.96, reflecting a 12% increase from the previous year, based on asset valuations as of June 30, 2024.

Summary

• NorthStar Healthcare Income has established an estimated value per share of $2.96 as of June 30, 2024.
• This valuation is based on the company's assets minus liabilities, divided by the number of outstanding shares.
• The valuation process involved an independent appraisal by Kroll, LLC, a third-party valuation firm.
• Kroll assessed the value of NorthStar's healthcare properties, including direct investments and unconsolidated investments, as well as healthcare borrowings.
• The estimated value of healthcare properties is $1.25 billion, compared to an aggregate cost of $1.62 billion.
• The gross estimated value of healthcare borrowings is $775.2 million, compared to an aggregate gross outstanding principal amount of $784.4 million.
• The estimated value per share increased by $0.32, or approximately 12%, compared to the $2.64 value as of June 30, 2023.
• The increase is attributed to improved performance across healthcare properties and the sale of the Trilogy Investment.
• The next estimated value per share is expected to be based on assets and liabilities as of June 30, 2025.

Sentiment

Score: 7

Explanation: The document conveys a positive sentiment due to the increase in estimated share value and improved operational performance, but also acknowledges risks and limitations associated with the valuation process.

Positives

• The estimated value per share increased by 12% year-over-year, indicating improved performance.
• Property revenues, net of operating expenses, saw a significant increase of 13.8% compared to the same period in 2023.
• Average occupancy rates for operating investments increased by 1.8% year-over-year, reaching 89.4%.
• The sale of the Trilogy Investment generated net proceeds exceeding its previous estimated value.
• The company's strategic capital investments in its properties contributed to the increase in estimated values.

Negatives

• The estimated value of healthcare properties is $1.25 billion, which is less than the aggregate cost of $1.62 billion.
• The estimated value of the Healthcare Properties, net of Healthcare Borrowings, totals approximately $478.0 million, compared to a cost of approximately $831.8 million, representing a 43% decline in net equity value based on cost.
• The estimated value per share does not reflect the company's enterprise value, which could be affected by disposition expenses, administrative costs, and other factors.
• The valuation is based on estimates and assumptions that may prove inaccurate.

Risks

• The estimated value per share may not reflect the actual trading price on a national securities exchange or the amount realized in a sale, merger, or liquidation.
• The value of assets and liabilities is subject to fluctuations due to various factors, including changes in interest rates, real estate values, and economic conditions.
• The methodologies used to establish the estimated value per share may not be acceptable to regulatory bodies.
• Changes in capitalization rates and discount rates could significantly impact the underlying value of the company's assets.
• There is no assurance that the company's expectations will be attained.

Future Outlook

The company expects the next estimated value per share to be based on assets and liabilities as of June 30, 2025, and intends to publish estimated values per share annually, but may do so more frequently.

Management Comments

• The Audit Committee relied in part on valuation and appraisal methodologies that Kroll and NorthStar Healthcare's management team believe are standard and acceptable in the real estate and non-listed REIT industries.
• The Board is ultimately and solely responsible for the establishment of the estimated value per share of NorthStar Healthcare's common stock.
• The Board considered all information provided in light of its own familiarity with NorthStar Healthcare's assets and unanimously approved the estimated value recommended by the Audit Committee.

Industry Context

The announcement reflects the ongoing valuation process for non-listed REITs, which often involves independent appraisals and is influenced by market conditions and property performance. The increase in value suggests a positive trend in the healthcare real estate sector, aligning with strong supply and demand fundamentals.

Comparison to Industry Standards

• The valuation methodology used by Kroll aligns with the Institute for Portfolio Alternatives Practice Guideline 2013-01, which is a standard for valuing publicly registered non-listed REITs.
• The use of both direct capitalization and discounted cash flow approaches is common in real estate valuation, particularly for properties with varying income stability.
• The company's engagement of an independent third-party valuation firm, Kroll, is a standard practice to ensure objectivity and transparency in the valuation process.
• The reported occupancy rates and revenue growth are key metrics that are often compared to industry benchmarks for healthcare real estate.

Stakeholder Impact

• Shareholders will see an increase in the estimated value of their shares.
• The improved performance and valuation may positively impact investor confidence.
• The company's strategic capital investments may benefit tenants and other stakeholders.

Next Steps

• The company will prepare its next estimated value per share based on assets and liabilities as of June 30, 2025.
• The company intends to publish estimated values per share annually, but may do so more frequently.

Key Dates

Keywords

estimated value per share, healthcare properties, real estate valuation, Kroll LLC, net asset value, occupancy rates, capitalization rates, discount rates, Trilogy Investment, mortgage loans